VirTarget: Virus-Informed Pharmacogenomics Framework Identifies Immunotherapies That Mitigate Epstein-Barr Virus-Driven Dysregulation in Multiple Sclerosis
Bekir Altas, Polymnia Georgiou, Marios Onisiforou, Panos Zanos, Anna Onisiforou
VirTarget evaluates MS immunotherapies' effects on EBV-driven dysregulation and host genetics, identifying therapies that reverse or reinforce EBV-MS interactions.
bioRxiv · Nov 3, 2025 · PreprintBioinformatics